Baricitinib in the Management of Coexisting Alopecia Areata and Atopic Dermatitis: A Case Report

    March 2025 in “ NATIONS UNIVERSITY INTERNATIONAL JOURNAL OF MULTI-DISCIPLINARY STUDIES ”
    Ieva Birbalaite, Kamilė Kalendraitė, Dominyka Stragytė
    TLDR Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.
    Baricitinib, a Janus kinase inhibitor, has shown promise in treating coexisting alopecia areata (AA) and atopic dermatitis (AD) by targeting shared immune pathways. In a case involving a 22-year-old female with both conditions, Baricitinib led to marked clinical improvement, including complete resolution of AD-associated rashes and significant hair regrowth, ultimately resolving AA-related bald patches. This case underscores Baricitinib's potential to reduce inflammation and enhance quality of life for patients with these autoimmune disorders.
    Discuss this study in the Community →